Print

How to Legally Break Up with Your Patient

Neda M. Ryan, Esq.
Clark Hill, PLC, Birmingham, MI

At some point toward the beginning of their careers, physicians are required to take the Hippocratic Oath in which the physician covenants to heal the sick or to prescribe measures for the good of the patient. Unfortunately, in an environment in which overdoses on prescription medication are quickly rising to the top of the list of causes of death, zealous adherence to this portion of the Oath could leave pain management physicians exposed to liability. Furthermore, blind adherence to the Oath is not a legal defense to injury or death associated with the misuse or diversion of prescriptions. Luckily, there are steps that pain management physicians can follow early on to promote a beneficial relationship for the patient and to minimize legal risk to the physician. Still, even when preventative steps do not produce the intended results, there are measures that can be taken to legally terminate the relationship with the patient.

Prescribing Controlled Substanances: Legitimate Medical Purpose

The laws and regulations surrounding prescribing include the Federal Controlled Substances Act, the Drug Enforcement Administration’s (DEA’s)regulations and guidance, and relevant state law and guidance from medical boards. The Supreme Court and the DEA have both made clear that controlled substances must be prescribed for a legitimate medical purpose by an individual practitioner acting in the usual course of his or her professional practice. It is clear that this standard is vague and, thus, a physician’s prescribing is analyzed on a case-by-case basis.

Warning Signs for Problematic Patients

The DEA has set forth a number of warning signs for problematic patients that include the following:

The appearance of one or more warning signs is not dispositive of inappropriate use or diversion of prescriptions. As such, the pain management physician should take into account each individual patient’s condition and medical history prior to determining whether action must be taken.

Proactive Steps You Can Take Now

The DEA does not require that pain management physicians prevent all instances of diversion and abuse. It also does not require that all drug abusers be denied all drugs. Rather, law enforcement officials will look to the steps the pain management physicians took to meet his or her legal responsibilities to prevent diversion and abuse. The questions that will be considered include the following:

The determination is extremely fact specific with special attention being given to those patients who are known drug abusers.

In addition to DEA regulations, there are many other steps pain management physicians may take to prevent abuse and diversion of the medications they are prescribing to their patients:

Execute a Treatment Agreement—If the patient is at high risk for medication abuse, the physician may consider using a Treatment Agreement that sets forth the obligations of the patient with respect to the medication as well as the consequences for failure to adhere to the agreement. Specifically, the Treatment Agreement could address the following: obtaining medications (or certain medications) from a single source, safeguarding the medications, the use of illegal substances, standards or requirements for refills, submission for drug testing, terminating the relationship for failure to comply and monitoring any state databases, as applicable.

In addition to the steps noted above, it is important that all providers consult their own state’s laws and regulations with respect to prescribing, especially as they relate to prescriptions for controlled substances.

The Break-Up

Sometimes, pain management physicians will find that despite all of the preventative measures they took to prevent abuse or diversion, the patient still shows signs that he or she is diverting or abusing the medications prescribed to him or her. Some reasons for terminating the relationship include: (1) the patient fails to comply with a Treatment Agreement or other terms set forth by the physician, (2) the patient is unreasonably demanding, and (3) the patient threatens the provider or staff.

When the issue of breaking up with a patient arises, concerns regarding patient abandonment also arise. Abandonment is defined as the termination of a professional relationship between the physician and patient at an unreasonable time and without giving the patient a chance to find a replacement. Mere termination of the relationship does not amount to abandonment. Abandonment may arise when the relationship is terminated at a critical stage of the treatment, without good reason or sufficient notice and the patient was injured as a result.

To properly terminate the relationship, physicians including pain medicine specialists should take the following steps:

Of course, it is important to recognize that some states may have laws that specifically define abandonment and set forth a process that must be followed to ensure terminated patients are not abandoned.

According to the DEA, in 2006, more than 6 million Americans were abusing prescription drugs—exceeding the number of Americans abusing cocaine, heroin, hallucinogens and inhalants, combined. Thus it is with great fervor that both State and Federal agencies have turned their attention to preventing diversion and abuse of controlled substances. That is why pain management physicians must be aware of preventative steps they can take to prevent abuse and diversion of prescription drugs as well as know their legal rights when treating a patient who has turned south, leaving the physician with little choice but to break up.


Neda M. Ryan, Esq. is an associate with Clark Hill, PLC in the firm’s Birmingham, MI office. Ms. Ryan practices in all areas of health care law, assisting clients with transactional and corporate matters; representing providers and suppliers in health care litigation matters; providing counsel regarding compliance and reimbursement matters; and representing providers and suppliers in health care litigation matters; providing counsel  regarding compliance and reimbursement matters; and representing providers and suppliers in third party payer audit appeals. She can be reached at (248) 998-5884 or at nryan@clarkhill.com